It’s time once again to network and facilitate at BIO-Europe bringing the international life science community together to partner from anywhere in the world. BIO-Europe brings together 4,000 global biopharma executives to engage in over 27,000 one-to-one meetings.
Meet Kam Dhaliwal, Senior VP Business Development & Alliance Management to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant, phenotypically characterised, offering predictive, in vitro, human cells for drug screening, toxicity testing, regenerative medicine, and tissue engineering applications.
Click on the button below to arrange a meeting with Kam.
